Formidable Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$491K Sell
647
-200
-24% -$151K 0.07% 242
2026
Q2
$528K Hold
847
– – 0.08% 226
2026
Q1
$654K Sell
847
-30
-3% -$23K 0.1% 187
2025
Q4
$677K Sell
877
-200
-19% -$136K 0.1% 199
2025
Q3
$606K Hold
1,077
– – 0.1% 203
2025
Q2
$565K Buy
1,077
+161
+18% +$89.9K 0.09% 212
2025
Q1
$581K Sell
916
-3
-0.3% -$2.06K 0.1% 204
2024
Q4
$655K Buy
919
+131
+17% +$110K 0.11% 184
2024
Q3
$828K Sell
788
-38
-5% -$42.3K 0.13% 150
2024
Q2
$868K Sell
826
-49
-6% -$47.5K 0.14% 141
2024
Q1
$842K Buy
875
+91
+12% +$86.5K 0.14% 152
2023
Q4
$689K Sell
784
-19
-2% -$15.6K 0.14% 140
2023
Q3
$661K Sell
803
-300
-27% -$236K 0.15% 145
2023
Q2
$793K Buy
1,103
+184
+20% +$142K 0.17% 114
2023
Q1
$755K Sell
919
-904
-50% -$682K 0.16% 114
2022
Q4
$1.32M Hold
1,823
– – 0.3% 63
2022
Q3
$1.26M Buy
1,823
+43
+2% +$27.1K 0.29% 65
2022
Q2
$1.05M Buy
1,780
+212
+14% +$138K 0.24% 81
2022
Q1
$1.1M Buy
1,568
+98
+7% +$62K 0.21% 90
2021
Q4
$928K Buy
1,470
+147
+11% +$90.4K 0.18% 112
2021
Q3
$801K Buy
+1,323
New +$821K 0.15% 129

Other funds holding REGN

Formidable Asset Management's REGN Position: Q3 2026 in Review

Formidable Asset Management reduced its Regeneron Pharmaceuticals (REGN) stake by 24% in Q3 2026, selling an estimated $151K and leaving 647 shares worth $491K. The position accounts for 0.07% of the portfolio, ranked #242.

Formidable Asset Management first reported a position in REGN in Q3 2021 and has held it in 21 quarters since. The position peaked at $1.32M in Q4 2022. 607 funds tracked by Wall St. Rank hold REGN as of Q3 2026.

  • Formidable Asset Management held 647 shares of Regeneron Pharmaceuticals worth $491K as of Q3 2026.
  • Formidable Asset Management sold 200 Regeneron Pharmaceuticals shares in Q3 2026, an estimated $151K.
  • Regeneron Pharmaceuticals made up 0.07% of Formidable Asset Management's portfolio in Q3 2026, its #242 holding.
  • Formidable Asset Management first reported a position in Regeneron Pharmaceuticals in Q3 2021 and has held it in 21 quarters since.
  • Formidable Asset Management's Regeneron Pharmaceuticals position peaked at $1.32M in Q4 2022.
  • 607 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.

Based on Formidable Asset Management's 13F filing for Q3 2026, filed 3 Nov 2026.